Abstract:To determine whether protein tyrosine kinase (PTK) modulates volume-sensitive chloride current (ICl.vol) in human atrial myocytes and to identify the PTKs involved, we studied the effects of broad-spectrum and selective PTK inhibitors and the protein tyrosine phosphatase (PTP) inhibitor orthovanadate (VO4−3). ICl.vol evoked by hyposmotic bath solution (0.6-times isosmotic, 0.6T) was enhanced by genistein, a broad-spectrum PTK inhibitor, in a concentration-dependent manner (EC50 = 22.4 μM); 100 μM genistein stimulated ICl.vol by 122.4 ± 10.6%. The genistein-stimulated current was inhibited by DIDS (4,4′-diisothiocyanostilbene-2,2′-disulfonic acid, 150 μM) and tamoxifen (20 μM), blockers of ICl.vol. Moreover, the current augmented by genistein was volume dependent; it was abolished by hyperosmotic shrinkage in 1.4T, and genistein did not activate Cl− current in 1T. In contrast to the stimulatory effects of genistein, 100 μM tyrphostin A23 (AG 18) and A25 (AG 82) inhibited ICl.vol by 38.2 ± 4.9% and 40.9 ± 3.4%, respectively. The inactive analogs, daidzein and tyrphostin A63 (AG 43), did not alter ICl.vol. In addition, the PTP inhibitor VO4−3 (1 mM) reduced ICl.vol by 53.5 ± 4.5% (IC50 = 249.6 μM). Pretreatment with VO4−3 antagonized genistein-induced augmentation and A23- or A25-induced suppression of ICl.vol. Furthermore, the selective Src-family PTK inhibitor PP2 (5 μM) stimulated ICl.vol, mimicking genistein, whereas the selective EGFR (ErbB-1) kinase inhibitor tyrphostin B56 (AG 556, 25 μM) reduced ICl.vol, mimicking A23 and A25. The effects of both PP2 and B56 also were substantially antagonized by pretreatment with VO4−3. The results suggest that ICl.vol is regulated in part by the balance between PTK and PTP activity. Regulation is complex, however. Src and EGFR kinases, distinct soluble and receptor-mediated PTK families, have opposing effects on ICl.vol, and multiple target proteins are likely to be involved.

EGFR Tyrosine Kinase Regulates Human Small-Conductance Ca2+-activated K+ (hskca1) Channels Expressed in HEK-293 Cells.

Both EGFR Kinase and Src-related Tyrosine Kinases Regulate Human Ether-À-go-go-related Gene Potassium Channels.

Genistein and Tyrphostin AG556 Inhibit Inwardly-Rectifying Kir2.1 Channels Expressed in HEK 293 Cells Via Protein Tyrosine Kinase Inhibition

Epidermal Growth Factor Receptor Tyrosine Kinase Regulates the Human Inward Rectifier Potassium K(Ir)2.3 Channel, Stably Expressed in Hek 293 Cells

Epidermal Growth Factor Receptor Tyrosine Kinase Stimulates Human Inward Rectifier Potassium (kir2.3) Channels

Genistein and Tyrphostin AG556 Decrease Ultra‐rapidly Activating Delayed Rectifier K+ Current of Human Atria by Inhibiting EGF Receptor Tyrosine Kinase

Modulation of Human Cardiac Transient Outward Potassium Current by Egfr Tyrosine Kinase and Src-Family Kinases

Tyrphostin AG556 Increases the Activity of Large Conductance Ca2+‐activated K+ Channels by Inhibiting Epidermal Growth Factor Receptor Tyrosine Kinase

The calcium-dependent activity of large-conductance, calcium-activated K+ channels is enhanced by Pyk2- and Hck-induced tyrosine phosphorylation.

Activation of epidermal growth factor receptor inhibits KCNQ2/3 current through two distinct pathways: membrane PtdIns(4,5)P2 hydrolysis and channel phosphorylation.

Activation of Epidermal Growth Factor Receptor Inhibits KCNQ2/3 Current through Two Distinct Pathways: Membrane PtdIns(4,5)P<sub>2</sub>Hydrolysis and Channel Phosphorylation

Differential Effects of Tyrosine Kinase Inhibitors on Volume-sensitive Chloride Current in Human Atrial Myocytes

Tyrosine kinase participates in α(1A)-adrenoceptor-mediated increase of intracellular calcium in human embryo kidney 293 cells

Tyrosine Kinase Participates in Alpha(1a)-Adrenoceptor-Mediated Increase of Intracellular Calcium in Human Embryo Kidney 293 Cells

Regulation of Transient Outward Current in Human Atrial Myocytes by Protein Tyrosine Kinase Pathway

Expression of Large Conductance Calcium-Activated Potassium Channels Decreases Cellular Protein Tyrosine Phosphorylation

Regulation of a Calcium-dependent Tyrosine Kinase in Vascular Smooth Muscle Cells by Angiotensin II and Platelet-derived Growth Factor

Tissue kallikrein induces SH-SY5Y cell proliferation via epidermal growth factor receptor and extracellular signal-regulated kinase1/2 pathway.

SKF-96365 Blocks Human Ether-À-go-go-related Gene Potassium Channels Stably Expressed in HEK 293 Cells.

α1 Adrenoceptor subtypes activates Ca2+ movement through stimulating a tyrosine protein kinase pathway in HEK293 cells

Molecular Basis for Genistein-Induced Inhibition of Kir2.3 Currents.